FANJ
BIS icon

Financial Architects (New Jersey)’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History

Financial Architects (New Jersey)’s Portfolio BIS Stock Details BIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4
Closed -$1K – 1483
2017
Q2 		$1K Hold
4
– – ﹤0.01% 1468
2017
Q1 		$1K Buy
+4
New +$944 ﹤0.01% 1505
2015
Q3 		– Sell
-25
Closed -$6K – 290
2015
Q2 		$6K Buy
+25
New +$6.2K ﹤0.01% 895

Other funds holding BIS

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Financial Architects (New Jersey)'s BIS Position: Q3 2017 in Review

Financial Architects (New Jersey) sold out of ProShares UltraShort NASDAQ Biotechnology (BIS) in Q3 2017, closing a stake of 4 shares — an estimated $1K sold.

Financial Architects (New Jersey) first reported a position in BIS in Q2 2015 and held it in 3 quarters. The position peaked at $6K in Q2 2015. 9 funds tracked by Wall St. Rank hold BIS as of Q3 2017.

  • Financial Architects (New Jersey) reported no remaining ProShares UltraShort NASDAQ Biotechnology position as of Q3 2017 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 4 ProShares UltraShort NASDAQ Biotechnology shares in Q3 2017, an estimated $1K.
  • Financial Architects (New Jersey) first reported a position in ProShares UltraShort NASDAQ Biotechnology in Q2 2015 and held it in 3 quarters.
  • Financial Architects (New Jersey)'s ProShares UltraShort NASDAQ Biotechnology position peaked at $6K in Q2 2015.
  • 9 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q3 2017.

Based on Financial Architects (New Jersey)'s 13F filing for Q3 2017, filed 23 Oct 2017.